1 Barker, DJ & Law, CM (1994) Birth weight and blood pressure in adolescence. Studies may be misleading. BMJ 308, 1634.
2 Adair, LS, Kuzawa, CW & Borja, J (2001) Maternal energy stores and diet composition during pregnancy program adolescent blood pressure. Circulation 104, 1034–1039.
3 Eriksson, R & Olsson, B (2004) Adapting genetic regulatory models by genetic programming. Biosystems 76, 217–227.
4 Langley-Evans, SC, Phillips, GJ & Jackson, AA (1994) In utero exposure to maternal low protein diets induces hypertension in weanling rats, independently of maternal blood pressure changes. Clin Nutr 13, 319–324.
5 Langley-Evans, SC, Gardner, DS & Jackson, AA (1996) Maternal protein restriction influences the programming of the rat hypothalamic–pituitary–adrenal axis. J Nutr 126, 1578–1585.
6 Rees, WD, Hay, SM, Brown, DS, et al. (2000) Maternal protein deficiency causes hypermethylation of DNA in the livers of rat fetuses. J Nutr 130, 1821–1826.
7 Lucas, A (2005) The developmental origins of adult health and well-being. Adv Exp Med Biol 569, 13–15.
8 Zambrano, E, Bautista, CJ, Deas, M, et al. (2006) A low maternal protein diet during pregnancy and lactation has sex- and window of exposure-specific effects on offspring growth and food intake, glucose metabolism and serum leptin in the rat. J Physiol 571, 221–230.
9 Langley, SC & Jackson, AA (1994) Increased systolic blood pressure in adult rats induced by fetal exposure to maternal low protein diets. Clin Sci (Lond) 86, 217–222, .
10 Macedo, GS, Ferreira, CL, Menegaz, A, et al. (2008) Correlation of serum leptin and insulin levels of pregnant protein-restricted rats with predictive obesity variables. Braz J Med Biol Res 41, 519–525.
11 Desai, M, Crowther, NJ, Ozanne, SE, et al. (1995) Adult glucose and lipid metabolism may be programmed during fetal life. Biochem Soc Trans 23, 331–335.
12 Daenzer, M, Ortmann, S, Klaus, S, et al. (2002) Prenatal high protein exposure decreases energy expenditure and increases adiposity in young rats. J Nutr 132, 142–144.
13 Thone-Reineke, C, Kalk, P, Dorn, M, et al. (2006) High-protein nutrition during pregnancy and lactation programs blood pressure, food efficiency, and body weight of the offspring in a sex-dependent manner. Am J Physiol Regul Integr Comp Physiol 291, R1025–R1030.
14 Langley-Evans, SC (2001) Fetal programming of cardiovascular function through exposure to maternal undernutrition. Proc Nutr Soc 60, 505–513.
15 Jackson, AA, Dunn, RL, Marchand, MC, et al. (2002) Increased systolic blood pressure in rats induced by a maternal low-protein diet is reversed by dietary supplementation with glycine. Clin Sci (Lond) 103, 633–639.
16 Petrie, L, Duthie, SJ, Rees, WD, et al. (2002) Serum concentrations of homocysteine are elevated during early pregnancy in rodent models of fetal programming. Br J Nutr 88, 471–477.
17 Brawley, L, Torrens, C, Anthony, FW, et al. (2004) Glycine rectifies vascular dysfunction induced by dietary protein imbalance during pregnancy. J Physiol 554, 497–504.
18 Cherif, H, Reusens, B, Ahn, MT, et al. (1998) Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet. J Endocrinol 159, 341–348.
19 McMillen, IC & Robinson, JS (2005) Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 85, 571–633.
20 Jiang, Y, Sun, T, Xiong, J, et al. (2007) Hyperhomocysteinemia-mediated DNA hypomethylation and its potential epigenetic role in rats. Acta Biochim Biophys Sin (Shanghai) 39, 657–667.
21 Hietaniemi, M, Santaniemi, M, Malo, E, et al. (2009) Gene expression profiles in fetal and neonatal rat offspring of energy-restricted dams. J Nutrigenet Nutrigenomics 2, 173–183.
22 Reeves, PG, Nielsen, FH & Fahey, GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939–1951.
23 Szeto, IM, Aziz, A, Das, PJ, et al. (2008) High multivitamin intake by Wistar rats during pregnancy results in increased food intake and components of the metabolic syndrome in male offspring. Am J Physiol Regul Integr Comp Physiol 295, R575–R582.
24 Sacco, SM, Jiang, JM, Reza-Lopez, S, et al. (2009) Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats. Menopause 16, 545–554.
25 Thompson, LU, Boucher, BA, Cotterchio, M, et al. (2007) Dietary phytoestrogens, including isoflavones, lignans, and coumestrol, in nonvitamin, nonmineral supplements commonly consumed by women in Canada. Nutr Cancer 59, 176–184.
26 Muniyappa, R, Lee, S, Chen, H, et al. (2008) Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294, E15–E26.
27 Remacle, C, Dumortier, O, Bol, V, et al. (2007) Intrauterine programming of the endocrine pancreas. Diabetes Obes Metab 9, Suppl. 2, 196–209.
28 Gluckman, PD & Hanson, MA (2004) The developmental origins of the metabolic syndrome. Trends Endocrinol Metab 15, 183–187.
29 Phillips, SM, Tang, JE & Morre, DR (2009) The role of milk- and soy-based protein in support of muscle protein synthesis and muscle protein accretion in young and elderly persons. J Am Coll Nutr 28, 343–354.
30 Bagley, PJ & Stipanuk, MH (1995) Rats fed a low protein diet supplemented with sulfur amino acids have increased cysteine dioxygenase activity and increased taurine production in hepatocytes. J Nutr 125, 933–940.
31 FitzGerald, RJ, Murray, BA & Walsh, DJ (2004) Hypotensive peptides from milk proteins. J Nutr 134, 980S–988S.
32 Mizuno, S, Nishimura, S, Matsuura, K, et al. (2004) Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease. J Dairy Sci 87, 3183–3188.
33 Nakamura, T, Mizutani, J, Sasaki, K, et al. (2009) Beneficial potential of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index: a preliminary study. J Med Food 12, 1221–1226.
34 FitzGerald, RJ & Meisel, H (2000) Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr 84, Suppl. 1, S33–S37.
35 Meisel, H (1993) Casokinins as bioactive peptides in the primary structure of casein. In Food Proteins: Structure and Functionality, pp. 67–75 [Schwenke, KD and Mothes, R, editors]. Weinheim, NY: VCH.
36 Saito, T (2008) Antihypertensive peptides derived from bovine casein and whey proteins. Adv Exp Med Biol 606, 295–317.
37 Foltz, M, van der Pijl, PC & Duchateau, GS (2010) Current in vitro testing of bioactive peptides is not valuable. J Nutr 140, 117–118.
38 Meisel, H (1997) Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers 43, 119–128.
39 Steegers-Theunissen, RP & Steegers, EA (2003) Nutrient–gene interactions in early pregnancy: a vascular hypothesis. Eur J Obstet Gynecol Reprod Biol 106, 115–117.
40 Hultberg, B, Andersson, A, Masson, P, et al. (1994) Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine. Scand J Clin Lab Invest 54, 417–422.
41 Verhoef, P, Steenge, GR, Boelsma, E, et al. (2004) Dietary serine and cystine attenuate the homocysteine-raising effect of dietary methionine: a randomized crossover trial in humans. Am J Clin Nutr 80, 674–679.
42 Fukada, S, Morita, T & Sugiyama, K (2008) Effects of various amino acids on methionine-induced hyperhomocysteinemia in rats. Biosci Biotechnol Biochem 72, 1940–1943.
43 Giltay, EJ, Hoogeveen, EK, Elbers, JM, et al. (1998) Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 139, 197–198.
44 Fonseca, V, Keebler, M, Dicker-Brown, A, et al. (2002) The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in Zucker rats. Metabolism 51, 783–786.
45 Randeva, HS (2003) Hormonal regulation of homocysteine. Metab Syndr Relat Disord 1, 121–128.
46 Dorner, G, Plagemann, A, Ruckert, J, et al. (1988) Teratogenetic maternofoetal transmission and prevention of diabetes susceptibility. Exp Clin Endocrinol 91, 247–258.
47 Aerts, L, Holemans, K & Van Assche, FA (1990) Maternal diabetes during pregnancy: consequences for the offspring. Diabetes Metab Rev 6, 147–167.
48 Dorner, G & Plagemann, A (1994) Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk in later life. Horm Metab Res 26, 213–221.
49 Silverman, BL, Rizzo, T, Green, OC, et al. (1991) Long-term prospective evaluation of offspring of diabetic mothers. Diabetes 40, Suppl. 2, 121–125.
50 Plagemann, A, Harder, T, Kohlhoff, R, et al. (1997) Overweight and obesity in infants of mothers with long-term insulin-dependent diabetes or gestational diabetes. Int J Obes Relat Metab Disord 21, 451–456.
51 Cassidy, A & Griffin, B (1999) Phyto-oestrogens: a potential role in the prevention of CHD? Proc Nutr Soc 58, 193–199.
52 Nagao, T, Yoshimura, S, Saito, Y, et al. (2001) Reproductive effects in male and female rats of neonatal exposure to genistein. Reprod Toxicol 15, 399–411.
53 Amin, H, Holst, JJ, Hartmann, B, et al. (2008) Functional ontogeny of the proglucagon-derived peptide axis in the premature human neonate. J Pediatr 121, e180–e186.
54 Cotterchio, M, Boucher, BA, Kreiger, N, et al. (2008) Dietary phytoestrogen intake – lignans and isoflavones – and breast cancer risk (Canada). Cancer Causes Control 19, 259–272.
55 Kavanagh, K, Jones, KL, Zhang, L, et al. (2008) High isoflavone soy diet increases insulin secretion without decreasing insulin sensitivity in premenopausal nonhuman primates. Nutr Res 28, 368–376.
56 Noriega-Lopez, L, Tovar, AR, Gonzalez-Granillo, M, et al. (2007) Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones. J Biol Chem 282, 20657–20666.
57 Dolinoy, DC, Weidman, JR, Waterland, RA, et al. (2006) Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114, 567–572.